Viyash Scientific · NSE: VIYASH · BSE: 512529
Q4 FY22 results · Jan–Mar 2022
Viyash Scientific reported revenue from operations of ₹383.71 crore (up 6.0% from Q4 FY21) and net profit of ₹10.04 crore (down 57.3% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 383.71 | 361.82 | +6.0% | 358.05 | +7.2% |
| Other income | 3.77 | 1.37 | +175.0% | 3.67 | +2.8% |
| Total income | 387.48 | 363.20 | +6.7% | 361.71 | +7.1% |
| Profit before tax | 18.61 | 29.01 | −35.9% | 23.61 | −21.2% |
| Net profit for the period | 10.04 | 23.52 | −57.3% | 18.56 | −45.9% |
| Attributable to shareholders of the company | 8.96 | 20.63 | −56.6% | 17.12 | −47.6% |
| EPS, basic (₹) | 0.36 | 0.84 | −57.1% | 0.69 | −47.8% |
| Net margin (%) | 2.6 | 6.5 | 5.2 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 63.67 | 69.48 | −8.4% | 59.19 | +7.6% |
| Other income | 5.77 | 5.92 | −2.5% | 5.70 | +1.3% |
| Total income | 69.44 | 75.40 | −7.9% | 64.89 | +7.0% |
| Profit before tax | 8.04 | 6.03 | +33.3% | 5.52 | +45.7% |
| Net profit for the period | 6.65 | 4.64 | +43.2% | 4.47 | +48.6% |
| EPS, basic (₹) | 0.27 | 0.19 | +42.1% | 0.18 | +50.0% |
| Net margin (%) | 10.4 | 6.7 | 7.6 |
Consolidated
- Filed with BSE
- 27 May 2022, 09:25 IST
- Board meeting
- 25 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 May 2022, 09:25 IST
- Board meeting
- 25 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE